Kai Rejeski, MD^1,2, Doris K. Hansen, MD³, David M. Cordas Dos Santos, MD^4*, Andre De Menezes Silva Corraes, MD^5*, Omar Castaneda, MD³, Christen M Dillard, MD^6*, Winfried Alsdorf^7*, Jan H. Frenking, MD^8*, Anna Purcarea, MD^9*, Saurabh Chhabra, MBBS^10*, Ciara Louise Freeman, PhD, MSc, FRCPC, MRCP³, Mirco Julian Friedrich, MD, PhD^8*, Mahmoud R. Gaballa, MD¹¹, Rebecca Gonzalez, PharmD^12*, Syed Hamza Bin Waqar, MD^12*, Yi Lisa Hwa, APRN, DNP, CNP⁵, Michael D. Jain, MD, PhD¹³, Ricardo D. Parrondo, MD¹⁴, Oren Pasvolsky, MD¹⁵, Wajma Shahbaz, MD^1*, Roni Shouval, MD, PhD², Genevieve Spiess, PAC^5*, Haily Stephens, PAC^5*, Sebastian Theurich, MD^1*, Florian Bassermann, MD^16*, Judith S. Hecker, MD^17*, Marc S. Raab^8*, Katja C. Weisel, MD⁷, Frederick L. Locke, MD¹³, Marion Subklewe, MD¹⁸, Krina K. Patel, MD, MSc¹⁹ and Yi Lin, MD, PhD⁵

¹Department of Medicine III, LMU University Hospital, LMU Munich, Munich, Germany
²Adult Bone Marrow Transplantation Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY
³Department of Blood and Marrow Transplantation and Cellular Immunotherapy, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL
⁴Dana-Farber Cancer Institute, Boston, MA
⁵Division of Hematology, Mayo Clinic, Rochester, MN
⁶Department of Lymphoma & Myeloma, MD Anderson Cancer Center, Houston, TX
⁷University Medical Center Hamburg-Eppendorf, Hamburg, Germany
⁸Heidelberg Myeloma Center, Department of Medicine V, University Hospital Heidelberg, Heidelberg, Germany
⁹Department of Medicine III and Center for Translational Cancer Research, Technical University of Munich (TUM), School of Medicine and Health, Munich, Germany
¹⁰Division of Hematology/Oncology, Mayo Clinic Arizona, Phoenix, AZ
¹¹Department of Lymphoma & Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX
¹²Department of Blood and Marrow Transplant and Cellular Immunotherapy, Moffitt Cancer Center, Tampa, FL
¹³Department of Blood and Marrow Transplantation and Cellular Immunotherapy, Moffitt Cancer Center, Tampa, FL
¹⁴Division of Hematology-Oncology, Mayo Clinic-Florida, Jacksonville, FL
¹⁵Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX
¹⁶Hospital Rechts der Isar, Internal Medicine III - Hematology and Oncology, Technical University of Munich, Munich, Germany
¹⁷Department of Medicine III, Hematology and Oncology, Technical University of Munich (TUM), School of Medicine and Health, Munich, Germany
¹⁸Department of Medicine III, LMU University Hospital, Munich, Germany
¹⁹M.D. Anderson Cancer Center, MD Anderson Cancer Center, Houston, TX

Doris K. Hansen, MD¹, Ciara Louise Freeman, PhD, MSc, FRCPC, MRCP¹, Meghan Menges^2*, Brett Reid^3*, Julieta Abraham-Miranda, PhD^2*, Kayla Reid, MS^4*, Luis Cuadrado Delgado^5*, Gabriel De Avila^6*, Laura B. Oswald, PhD^7*, Ariel F. Grajales-Cruz, MD⁴, Brandon Blue⁴, Rebecca Gonzalez, PharmD^8*, Salvatore Corallo^2*, David R. Noyes, MS^9*, Mark B. Meads, PhD^10*, Hien Liu, MD¹, Taiga Nishihori, MD³, Kenneth H. Shain, MD, PhD¹⁰, Rachid Baz, MD¹¹, Melissa Alsina, MD^12*, Omar Castaneda, MD¹, Frederick L. Locke, MD⁸ and Lauren C. Peres, PhD, MPH^13*

¹Department of Blood and Marrow Transplantation and Cellular Immunotherapy, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL
²Department of Clinical Science, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL
³Moffitt Cancer Center, Tampa, FL
⁴H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL
⁵Moffitt Cancer Center, Tampa
⁶H Lee Moffitt Cancer Center and Research Institute, Tampa, FL
⁷Department of Health Outcomes and Behavior, Moffitt Cancer Center, Tampa, FL
⁸Department of Blood and Marrow Transplant and Cellular Immunotherapy, Moffitt Cancer Center, Tampa, FL
⁹Department of Malignant Hematology, H. Lee Moffitt Cancer Center & Research Institute, Tampa, FL
¹⁰H. Lee Moffitt Cancer Center, Tampa, FL
¹¹H. Lee Moffitt Cancer Center & Research Institute, Tampa, FL
¹²Department of Blood and Marrow Transplant and Cellular Immunotherapy, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL
¹³Department of Cancer Epidemiology, Moffitt Cancer Center, Tampa, FL

Danai Dima, MD¹, Mariola A Vazquez-Martinez, MD², James A Davis, PharmD^3*, Utkarsh Goel, MBBS¹, Aimaz Afrough^4*, Aishwarya Sannareddy, MBBS^4*, Oren Pasvolsky, MD⁵, Beatrice Razzo, MD⁶, Rahul Banerjee, MD, FACP⁷, Jack Khouri, MD¹, Ariel Grajales-Cruz^2*, Alex Lieberman-Cribbin^8*, Masooma Shifa Rana^9*, Kelley Julian, PharmD^10*, Shaun DeJarnette^11*, Andrew J Portuguese, MD⁷, Mahmoud R. Gaballa, MD⁵, Gabriel De Avila^2*, Sandra Susanibar-Adaniya, MD⁶, Shahzad Raza, MD¹, Megan M Herr, PhD¹², Evguenia Ouchveridze, MD¹¹, Tiffany Richards, PhD, NP⁵, Hitomi Hosoya, MD, PhD⁹, Lekha Mikkilineni, MD, MA⁹, Gurbakhash Kaur, MD, MA¹³, Daniel Schrum, PharmD^14*, Omar Castaneda, MD¹⁵, Adriana Rossi, MD, MSc¹⁶, Chenyu Lin, MD¹⁴, Peter A. Forsberg, MD¹⁷, Yi Lin, MD, PhD¹⁸, Shebli Atrash, MD¹⁹, Douglas W Sborov, MD¹⁰, Kenneth H. Shain, MD, PhD², Peter M. Voorhees, MD¹⁹, Shambavi Richard, MD¹⁶, Alfred L. Garfall, MD⁶, Doris K. Hansen, MD², Surbhi Sidana, MD⁹, Krina K. Patel, MD, MSc⁵, Andrew J. Cowan, MD⁷, Larry D Anderson Jr., MD, PhD²⁰, Hans C. Lee, MD⁵, Faiz Anwer, MD¹, Christopher Ferreri, MD¹⁹ and Leyla O. Shune, MD¹¹

¹Cleveland Clinic Taussig Cancer Institute, Cleveland, OH
²H Lee Moffitt Cancer Center and Research Institute, Tampa, FL
³Medical University of South Carolina Hollings Cancer Center, Charleston, SC
⁴UT Southwestern Simmons Cancer Center, Dallas, TX
⁵The University of Texas MD Anderson Cancer Center, Houston, TX
⁶University of Pennsylvania Abramson Cancer Center, Philadelphia, PA
⁷University of Washington Fred Hutchinson Cancer Center, Seattle, WA
⁸Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY
⁹Stanford University, Stanford, CA
¹⁰University of Utah Huntsman Cancer Institute, Salt Lake City, UT
¹¹University of Kansas Medical Center, Kansas City, KS
¹²Roswell Park Comprehensive Cancer Center, Buffalo, NY
¹³Harold C. Simmons Comprehensive Cancer Center, University of Texas Southwestern Medical Center, Dallas, TX
¹⁴Duke University Cancer Institute, Durham, NC
¹⁵Department of Blood and Marrow Transplantation and Cellular Immunotherapy, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL
¹⁶Icahn School of Medicine at Mount Sinai Tisch Cancer Institute, New York, NY
¹⁷University of Colorado Cancer Center, Aurora, CO
¹⁸Division of Hematology, Mayo Clinic, Rochester, MN
¹⁹Atrium Health Levine Cancer Institute, Charlotte, NC
²⁰Harold C. Simmons Comprehensive Cancer Center, UT Southwestern Medical Center, Dallas, TX

Elias K. Mai, MD^1*, Andrea Manubens, PhD^2*, Mattia D'Agostino, MD^3*, David A. Cairns, PhD^4*, Alessandra Larocca, MD, PhD^3*, Juan José Lahuerta Palacios, MD, PhD^5*, Ruth Wester, MD, PhD^6*, Uta Bertsch, MD^1,7*, Anders Waage, MD, PhD^8*, Elena Zamagni, MD^9,10*, María-Victoria Mateos, MD, PhD¹¹, Daniele Dall'Olio, PhD^12*, Niels W.C.J. van de Donk, MD, PhD^13*, Graham Jackson, MD^14*, Serena Rocchi, MD, PhD^9,10*, Hans Salwender, MD^15*, Joan Bladé, MD, PhD^16*, Bronno van der Holt, PhD^6,17*, Gastone Castellani, PhD^10*, Katja C. Weisel, MD¹⁸, Francesca Gay, MD, PhD^3*, Sonja Zweegman, MD, PhD¹³, Michele Cavo, MD^9,10*, Jesus Maria Hernandez Rivas, MD^19,20, Benedetto Bruno, MD, PhD³, Gordon Cook, PhD, DSc^4*, Martin F Kaiser, MD²¹, Hartmut Goldschmidt, MD^1,7, Mario Boccadoro, MD²², Jesús F. San-Miguel, MD, PhD²³ and Pieter Sonneveld, MD⁶

¹Internal Medicine V, Hematology, Oncology and Rheumatology, Heidelberg University Hospital, Heidelberg, Germany
²Clínica Universidad de Navarra, Cancer Center Clínica Universidad de Navarra, Madrid, Spain
³Division of Hematology, AOU Città della Salute e della Scienza di Torino, University of Torino and Department of Molecular Biotechnology and Health Sciences, University of Torino, Torino, Italy
⁴Leeds Cancer Research UK Clinical Trials Unit, Leeds Institute of Clinical Trials Research, University of Leeds, Leeds, United Kingdom
⁵Research Institute of the Hospital Universitario 12 de Octubre and Board of the Spanish Myeloma Group (PETHEMA/GEM), Madrid, Spain
⁶Department of Hematology, Erasmus MC Cancer Institute, Rotterdam, Netherlands
⁷National Center for Tumor Diseases Heidelberg, Heidelberg, Germany
⁸Institute of Clinical and Molecular Medicine, Norwegian University of Science and Technology, and Research Department, St Olavs Hospital, Trondheim, Norway
⁹IRCCS Azienda Ospedaliero-Universitaria di Bologna, Istituto di Ematologia “Seràgnoli”, Bologna, Italy
¹⁰Dipartimento di Scienze Mediche e Chirurgiche, Università di Bologna, Bologna, Italy
¹¹Complejo Asistencial Universitario de Salamanca/IBSAL/CIC/CIBERONC, Salamanca, Spain
¹²IRCCS Istituto delle Scienze Neurologiche di Bologna, Bologna, Italy
¹³Department of Hematology, Amsterdam UMC, Cancer Center Amsterdam, Vrije Universiteit Amsterdam, Amsterdam, Netherlands
¹⁴University of Newcastle upon Tyne, Newcastle upon Tyne, United Kingdom
¹⁵Asklepios Tumorzentrum Hamburg, AK Altona, AK St Georg, Hamburg, Germany
¹⁶Hospital Clinic, IDIBAPS, Barcelona, Spain
¹⁷HOVON Foundation, Rotterdam, Netherlands
¹⁸Department of Oncology, Hematology and BMT, University Medical Center Hamburg-Eppendorf, Hamburg, Germany
¹⁹Department of Medicine, University of Salamanca, Institute of Biomedical Research of Salamanca (IBSAL), University of Salamanca – Cancer Research Center of Salamanca (IBMCC, USAL-CSIG), Salamanca, Spain
²⁰Hematology Department, Hospital Universitario de Salamanca (CAUSA/IBSAL), Salamanca, Spain
²¹The Institute of Cancer Research, London, United Kingdom and the Royal Marsden Hospital, London, United Kingdom
²²European Myeloma Network, EMN, Italy
²³Clínica Universidad de Navarra, CIMA, IDISNA, CIBER-ONC (CB16/12/00369), Pamplona, Spain

Jana Wobst^1*, Marietta Truger^1*, Natalie Wossidlo, PhD^1*, Constance Regina Baer, PhD¹, Stephan Hutter, PhD^1*, Manja Meggendorfer, PhD², Wolfgang Kern, MD¹, Torsten Haferlach, MD¹ and Claudia Haferlach, MD¹

¹MLL Munich Leukemia Laboratory, Munich, Germany
²MLL Munich Leukemia Laboratory, Munich, Bavaria, Germany

Bruno Paiva, PhD^1*, Irene Manrique^2*, Ethan G. Thompson, PhD^3*, Timothy B. Campbell, MD, PhD⁴, Camila Guerrero, PhD^1*, Nathan Martin^3*, Larry D Anderson Jr., MD, PhD⁵, Jesus G Berdeja, MD⁶, Sagar Lonial, MD^7*, Noopur Raje⁸, Yi Lin, MD, PhD⁹, Philippe Moreau, MD, PhD^10*, Jesús F. San-Miguel, MD, PhD¹¹, Nikhil C. Munshi, MD¹² and Shari Kaiser^13*

¹Department of Hematology, Centre for Applied Medical Research, Cancer Center Clinica Universidad de Navarra, University of Navarra, IdiSNA, CIBERONC, Pamplona, Spain
²Clinica Universidad De Navarra, Centro De Investigacion Medica Aplicada (CIMA),, Pamplona, ESP
³Bristol Myers Squibb, Princeton, NJ
⁴Bristol-Myers Squibb, Brisbane, CA
⁵Harold C. Simmons Comprehensive Cancer Center, UT Southwestern Medical Center, Dallas, TX
⁶Sarah Cannon Center For Blood Cancers, Nashville, TN
⁷Winship Cancer Institute of Emory University, Atlanta, GA
⁸Harvard Medical School, Massachusetts General Hospital Cancer Center, Boston, MA
⁹Division of Hematology, Mayo Clinic, Rochester, MN
¹⁰Department of Hematology, Nantes University Hospital, Nantes, France
¹¹Clínica Universidad de Navarra, Centro de Investigación Médica Aplicada, Universidad de Navarra, CCUN, IDISNA, CIBER-ONC CB16/12/00369, Pamplona, Spain, Pamplona, Spain
¹²Dana-Farber Cancer Institute, Boston, MA
¹³Bristol Myers Squibb, Seattle, WA